Cargando…
A novel therapeutic strategy for skeletal disorders: Proof of concept of gene therapy for X-linked hypophosphatemia
Adeno-associated virus (AAV) vectors are a well-established gene transfer approach for rare genetic diseases. Nonetheless, some tissues, such as bone, remain refractory to AAV. X-linked hypophosphatemia (XLH) is a rare skeletal disorder associated with increased levels of fibroblast growth factor 23...
Autores principales: | Zhukouskaya, Volha V., Jauze, Louisa, Charles, Séverine, Leborgne, Christian, Hilliquin, Stéphane, Sadoine, Jérémy, Slimani, Lotfi, Baroukh, Brigitte, van Wittenberghe, Laetitia, Danièle, Natalie, Rajas, Fabienne, Linglart, Agnès, Mingozzi, Federico, Chaussain, Catherine, Bardet, Claire, Ronzitti, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550245/ https://www.ncbi.nlm.nih.gov/pubmed/34705504 http://dx.doi.org/10.1126/sciadv.abj5018 |
Ejemplares similares
-
Impact of Early Conventional Treatment on Adult Bone and Joints in a Murine Model of X-Linked Hypophosphatemia
por: Cauliez, Axelle, et al.
Publicado: (2021) -
Growth hormone treatment improves final height in children with X-linked hypophosphatemia
por: André, Julia, et al.
Publicado: (2022) -
Development of Enthesopathies and Joint Structural Damage in a Murine Model of X-Linked Hypophosphatemia
por: Faraji-Bellée, Carole-Anne, et al.
Publicado: (2020) -
Increased prevalence of overweight and obesity in children with X-linked hypophosphatemia
por: Zhukouskaya, Volha V, et al.
Publicado: (2020) -
Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone
por: Ertl, Diana-Alexandra, et al.
Publicado: (2022)